Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats-Reference-Cited by-同舟云学术

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats

Published:2012-01 Issue:3 Volume:100 Page:607-615
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Barnum Christopher J.,Bhide Nirmal,Lindenbach David,Surrena Margaret A.,Goldenberg Adam A.,Tignor Stefanie,Klioueva Anna,Walters Hannah,Bishop Christopher

Funder

NIH

Center for Development and Behavioral Neuroscience at Binghamton University

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference73 articles.

1. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter;Arai;Synapse,2008

2. Electrolytic lesions of the locus coeruleus or 6-hydroxydopamine lesions of the medial forebrain bundle protect against excitotoxic damage in rat hippocampus;Arvin;Brain Res,1992

3. Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta;Barnum;Neuroscience,2008

4. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra;Bing;Brain Res,1994

5. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats;Bishop;J Neurosci Res,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of L-DOPA on gait abnormalities in a unilateral 6-OHDA rat model of Parkinson's disease;Physiology & Behavior;2024-07

2. The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease;Journal of Neurology;2024-05-08

3. Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets;Progress in Neurobiology;2024-01

4. Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments;Current Drug Discovery Technologies;2023-09

5. Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease;Psychopharmacology;2022-09-30